306 related articles for article (PubMed ID: 34638258)
1. Molecular Characterization of Prostate Cancers in the Precision Medicine Era.
Giunta EF; Annaratone L; Bollito E; Porpiglia F; Cereda M; Banna GL; Mosca A; Marchiò C; Rescigno P
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638258
[TBL] [Abstract][Full Text] [Related]
2. DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology.
Grypari IM; Tzelepi V; Gyftopoulos K
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511177
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
4. Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.
Ritch E; Fu SYF; Herberts C; Wang G; Warner EW; Schönlau E; Taavitsainen S; Murtha AJ; Vandekerkhove G; Beja K; Loktionova Y; Khalaf D; Fazli L; Kushnir I; Ferrario C; Hotte S; Annala M; Chi KN; Wyatt AW
Clin Cancer Res; 2020 Mar; 26(5):1114-1125. PubMed ID: 31744831
[TBL] [Abstract][Full Text] [Related]
5. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for characterization and therapeutic orientation in castration-resistant prostate cancer.
Plata Bello A; Tamayo Jover MA; Gutierrez Nicolas F; Acosta López S; Concepción Masip T; Plata Bello J
Arch Esp Urol; 2022 Mar; 75(2):195-202. PubMed ID: 35332889
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs.
Puche-Sanz I; Alvarez-Cubero MJ; Pascual-Geler M; Rodríguez-Martínez A; Delgado-Rodríguez M; García-Puche JL; Expósito J; Robles-Fernández I; Entrala-Bernal C; Lorente JA; Cózar-Olmo JM; Serrano MJ
Oncotarget; 2017 Sep; 8(41):70472-70480. PubMed ID: 29050295
[TBL] [Abstract][Full Text] [Related]
9. [The Clinical Utility of Liquid Biopsies as Biomarkers in Metastatic Prostate Cancer].
Sumiyoshi T; Akamatsu S
Gan To Kagaku Ryoho; 2021 Oct; 48(10):1203-1208. PubMed ID: 34657048
[TBL] [Abstract][Full Text] [Related]
10. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
[TBL] [Abstract][Full Text] [Related]
11. Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.
Davoudi F; Moradi A; Becker TM; Lock JG; Abbey B; Fontanarosa D; Haworth A; Clements J; Ecker RC; Batra J
Curr Treat Options Oncol; 2023 Oct; 24(10):1451-1471. PubMed ID: 37561382
[TBL] [Abstract][Full Text] [Related]
12. Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature.
Singhal U; Wang Y; Henderson J; Niknafs YS; Qiao Y; Gursky A; Zaslavsky A; Chung JS; Smith DC; Karnes RJ; Chang SL; Feng FY; Palapattu GS; Taichman RS; Chinnaiyan AM; Tomlins SA; Morgan TM
Mol Cancer Res; 2018 Apr; 16(4):643-654. PubMed ID: 29453313
[TBL] [Abstract][Full Text] [Related]
13. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995
[TBL] [Abstract][Full Text] [Related]
14. Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.
Nebot-Bral L; Brandao D; Verlingue L; Rouleau E; Caron O; Despras E; El-Dakdouki Y; Champiat S; Aoufouchi S; Leary A; Marabelle A; Malka D; Chaput N; Kannouche PL
Eur J Cancer; 2017 Oct; 84():290-303. PubMed ID: 28846956
[TBL] [Abstract][Full Text] [Related]
15. Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.
Herberts C; Murtha AJ; Fu S; Wang G; Schönlau E; Xue H; Lin D; Gleave A; Yip S; Angeles A; Hotte S; Tran B; North S; Taavitsainen S; Beja K; Vandekerkhove G; Ritch E; Warner E; Saad F; Iqbal N; Nykter M; Gleave ME; Wang Y; Annala M; Chi KN; Wyatt AW
Eur Urol; 2020 Dec; 78(6):834-844. PubMed ID: 32451180
[TBL] [Abstract][Full Text] [Related]
16. Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.
Nuhn P; De Bono JS; Fizazi K; Freedland SJ; Grilli M; Kantoff PW; Sonpavde G; Sternberg CN; Yegnasubramanian S; Antonarakis ES
Eur Urol; 2019 Jan; 75(1):88-99. PubMed ID: 29673712
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer.
Kwan EM; Wyatt AW
Prostate; 2022 Aug; 82 Suppl 1():S25-S36. PubMed ID: 35657159
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy and prostate cancer. Current evidence applied to clinical practice.
Puche-Sanz I; Rodríguez-Martínez A; Garrido-Navas MC; Robles-Fernández I; Vázquez-Alonso F; Álvarez Cubero MJ; Lorente-Acosta JA; Serrano-Fernández MJ; Cózar-Olmo JM
Actas Urol Esp (Engl Ed); 2020 Apr; 44(3):139-147. PubMed ID: 31839360
[TBL] [Abstract][Full Text] [Related]
19. Future directions for precision oncology in prostate cancer.
Mizuno K; Beltran H
Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S86-S96. PubMed ID: 35657153
[TBL] [Abstract][Full Text] [Related]
20. Liquid Biopsies in a Veteran Patient Population With Advanced Prostate and Lung Non-Small Cell Carcinomas: A New Paradigm and Unique Challenge in Personalized Medicine.
Dalal S; Petersen J; Jhala D
Fed Pract; 2021 Jan; 38(1):8-14. PubMed ID: 33574643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
